RESEARCH-USE BIOSIMILAR ANTIBODY
Dacetuzumab
Monoclonal antibody · IgG1
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research.
TARGETTNFRSF5
YMonoclonal antibody
CATALOGSC-BS-648
CATALOG NUMBERSC-BS-648
MOLECULAR WEIGHTApprox. 145 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research.
Dacetuzumab is a recombinant research-use antibody directed against TNFRSF5.